Group – Fuad Fares Lab

Group Leader

B.Sc. Biology, Hebrew University, Jerusalem, Israel
M.Sc. Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
D.Sc, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
Post-Doctorate, Department of Molecular Biology & Pharmacology, Washington University, Saint-Louis, MO, USA
Head of the Molecular Genetic Laboratory, at Carmel Medical Center, Haifa, Israel, for 23 years (1992-2015)
Faculty member at the Faculty of Medicine, Technion-Israel Institute of Technology (2000-2004)
Faculty member at Department of Human Biology University of Haifa, Israel (2004-present)
Member of the Israel Council for Higher Education, for 15 years (2002-2017)
Developer of ELONVA, [FSH long acting], acquired by Merck & Co. (NYSE: MRK),
Founder of the technology behind PROLOR Biotech (A Start Up Company) for “Designing long acting recombinant proteins”
Founder of CanCurX, for “development of new strategies for treatment of cancer” at University of Haifa

Lab Manager
Dr. Rinat Bar-Shalom
E-mail: rbar-shal@staff.haifa.ac.il
Tel: 972 4 8288782

Research Associate
Dr. Naiel Azzam
E-mail: nazzam3@univ.haifa.ac.il
Tel: 972 4 8288782